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The brain is capable of plasticity, so that the structural and functional loss that are 
caused by cortical injury may recover. Neuroinflammatory response can greatly influence 
post-injury recovery by modulating synaptic plasticity. In our previous work, mesenchymal 
derived exosomes were found to promote functional recovery by converting microglia from 
a pro-inflammatory state to an anti-inflammatory state in aged rhesus monkeys after 
cortical injury in the primary motor cortex. In the present project, we demonstrated the 
effects of exosomes on synaptic changes and synapse-microglia interactions after lesion in 
the same monkeys. To further investigate the effects of modulating neuroinflammation on 
synaptic changes after injury, we also investigated dietary curcumin, an anti-inflammatory 
substance, in a separate group of monkeys. Both treatments showed an effect as 
neuroinflammatory modulators that reduced the density of microglial markers, Iba-
1/P2RY12. However, the cortical injury induced synaptic loss was reversed by the 
exosome treatment, whereas the other anti-inflammatory treatment, curcumin, did not 
show the same effect. Our results are consistent with previous study that cortical injury 
induced synaptic loss and microglia activation. Exosomes can both reduce inflammation 
and synapse loss after injury, but curcumin only showed anti-inflammatory effects. Overall, 
these data suggested that exosomes and curcumin had different mechanisms of how to 
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1.1 Cortical injury, inflammation and synaptic plasticity 
Stroke is a major cause of brain damage worldwide and it results in multiple 
disabilities. According to the report from American Heart Association in 2019, stroke is 
the 5th cause of death in the United States, and ischemic stroke constitutes the majority of 
all strokes (Benjamin et al., 2019). Ischemic stroke is caused by the occlusion of a blood 
vessel due to either cerebral embolism or thrombosis (Donnan et al., 2008). This occlusion 
of blood vessels leads to a deprivation of blood glucose and oxygen in associated brain 
tissue, and ultimately results in metabolic compromise, overactivation of glutamate 
receptors, oxidative stress, calcium overload, upregulation of adhesion molecules on 
endothelial cells, and neuronal death at the end (Taylor & Sansing, 2013; Candelario-Jalil, 
2009). The initial occlusion may further induce a secondary thrombosis and cause more 
dysfunctions in downstream microvessels (Zhang & Chopp, 2016). After the stroke, further 
damage in surrounding tissue can be triggered by the disruption of the blood-brain barrier 
(BBB) and other dynamic alternations of neurovascular unit that includes endothelial cells, 
vascular smooth muscle, glia, neurons, and relevant tissue matrix proteins (Zhang & Chopp, 
2016). The brain is known for its spontaneous plasticity, so it can undergo certain 
compensatory rearrangements or remodeling events after the stroke in order to recover 
from structural and functional loss caused by the ischemic injury (Cramer & Chopp, 2000). 
The plasticity-mediated changes include axonal sprouting and reorganization, dendritic or 
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synaptic changes, inflammatory alternation, immune adaptation, neurogenesis, gliogenesis, 
and angiogenesis (Daadi et al., 2010).   
The reduction of blood flow during ischemia causes the loss of spines and dendritic 
structure of neurons, which therefore leads to the impairment of synaptic connections and 
associated functional and structural loss (Winship & Murphy, 2009). As one of the most 
crucial structures in brain plasticity, synapses work as a communication site between a 
presynaptic and a postsynaptic neuron. An action potential can trigger the presynaptic 
release of neurotransmitters, which bind with postsynaptic receptors, and therefore the 
signal is transmitted (Shen & Cowan, 2010).  
 
1.2 Excitatory and inhibitory synaptic remodeling in post-injury recovery  
Previous studies found elevated rates of synaptogenesis of excitatory synapses in 
peri-infarct regions during post-stroke recovery (Brown et al., 2007). Excitatory 
glutamatergic synaptic remodeling is crucial for plasticity in neuronal networks. Glutamate 
transmission through AMPA receptor is a major pathway that affects excitability of 
neurons (Carmichael, 2012). AMPA receptors are involved in fast excitatory synaptic 
transmission and long-lasting synaptic plasticity. Upregulation of AMPA receptor 
signaling can enhance excitatory glutamatergic transmission and promote motor recovery, 
while blocking which can impair limb motor control (Carmichael, 2012). The mechanism 
may involve the downstream effect on brain-derived neurotrophic factor (BDNF). BDNF 
can promote the recovery by involving in the formation of long term potentiation (LTP) 
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and neuronal plasticity including synapse development, dendritic and axonal sprouting 
(Carmichael, 2012). 
The role of alternated excitatory signal transmission in post-stroke recovery has 
been studied for decades but still not fully understood. Glutamate is the major excitatory 
neurotransmitter in the central nervous system. It is stored and transported into synaptic 
vesicles by presynaptic vesicular glutamate transporters (VGLUTs), which are used as 
molecular markers of glutamate’s exocytotic release (Herzog et al., 2006). Isoforms of 
VGLUT including VGLUT1 to 3 have similar uptake characteristics but are expressed at 
different locations which therefore determine glutamatergic phenotypes of neurons and 
potential various excitability (Herzog et al., 2006). In the adult brain, VGLUT1 is 
expressed by excitatory neurons in the cerebral and cerebellar cortices, hippocampus and 
some nuclei of thalamus, while VGLUT2 is expressed mainly by subcortical glutamatergic 
neurons from the thalamus to the spinal cord (Fremeau et al., 2001; Herzog et al., 2006). 
In addition, in the cerebral cortex, layer IV and VI express VGLUT2 while other layers 
express mainly VGLUT1 (Fremeau et al., 2001). The complementary expression pattern 
implies some potential differences between the properties of VGLUT isoforms and may 
result in various synaptic plasticity of synapses expressing different isoforms (Fremeau et 
al., 2004). The difference of VGLUT isoforms expression are suggested to correlate with 
glutamate packaging and releasing (Fremeau et al., 2004). Synapses expressing VGLUT1 
such as hippocampus and parallel fiber synapses in cerebellum are found to have lower 
probability of glutamate release while synapses express VGLUT2 display a higher 
probability such as climbing fiber synapses in cerebellum (Fremeau et al., 2004). This 
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correlation may indicate the differences in membrane trafficking of VGLUT1 and 2 
(Fremeau et al., 2004). 
Compared to the diverse properties in the transportation of glutamate, downstream 
receptors are more directly related to LTP that contributes to functional recovery after the 
stroke. AMPA receptors (AMPARs), as mentioned before, regulate the fastest excitatory 
synaptic transmission and are mainly located postsynaptically (Bassani et al., 2009). They 
contain four distinct subunits named GluR1 to GluR4 with various cytoplasmic carboxy-
terminal domains, which can regulate functions of AMPA receptors (Bassani et al., 2009). 
Each subunit plays distinct roles in regulating AMPAR signal transmission and contributes 
differently to synaptic plasticity (Meng et al., 2003). GluR1 is important to synaptic 
transmission for LTP by involving in NMDA receptor-dependent synaptic delivery of 
AMPA receptors (Meng et al., 2003). The GluR2/3, on the other hand, is relevant to 
multiple activities including stabilizing basal synaptic responses, AMPARs trafficking 
process, synaptic plasticity, and dendritic growth (Meng et al., 2003; Bassani et al., 2009). 
N-terminal domain of GluR2 is shown to promote dendritic spines formation and 
enlargement, enhance presynaptic development, manipulate AMPAR-associated synaptic 
transmission which directly influences mini frequency of synapses (Saglietti et al., 2007).  
In addition to excitatory synaptic signaling, inhibitory signaling pathway plays a 
crucial role in synaptic plasticity. Diffusional inhibitory transmission, also known as tonic 
inhibition, is mediated by extrasynaptic GABAA receptors so that they can control overall 
membrane potential of the neuron and its excitability (Glykys & Mody, 2007). Smaller 
 
5 
tonic GABA current would make a cell more depolarized, and therefore the cell is more 
likely to fire in response to a given excitatory input, meaning more excitability it has 
(Carmichael, 2012). Higher excitability can be supportive to long-term excitable responses 
and lead to higher possibility of long-term potentiation (LTP) that contribute to learning 
and memory processes (Carmichael, 2012). A previous study demonstrated reduced 
GABAA receptor density in rodent models of cerebral ischemia (Schwartz-Bloom & Sah, 
2001). After the stroke, the ischemic penumbra area was found to have increased tonic 
GABAergic transmission that lasted for more than one month (Carmichael, 2012). In 
studies with monkey models of stroke, activating GABAA receptors in medial motor cortex 
with a GABA agonist was found to increase error rates during a motor task, which indicated 
that the activation of GABA signals might be negatively related to effective plasticity and 
functional linkage of neurons for complex motor skills (Kim et al., 2014).  
Researchers suggested that the GABA associated lower excitability of neurons in 
recovering motor cortex was due to the lower level of GABA uptake protein GAT-3/4 in 
reactive astrocytes (Clarkson et al., 2010). In this study, behavioral and motor recovery 
was promoted by blocking this tonic inhibition by using a GABAA receptor !5 inverse 
agonist or genetic deletion of GABAA receptor !5 subunit (Clarkson et al., 2010). Drugs 
that block tonic GABA signaling were shown to elevate neuronal excitability, enhance LTP 
formation, and therefore lead to a long-lasting enhancement in both learning and memory 
formation (Carmichael, 2012).  
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However, the effects of glutamate and GABA signaling can be contradictory in 
different phases after the stroke. In the acute phase after the ischemia, brain excitability is 
enhanced and deleterious, so it is neuroprotective to block glutamate transmission or 
enhance GABA inhibition (Carmichael, 2012). It is the opposite in the chronic recovery 
phase that tonic GABA inhibition currents are enhanced and synaptic glutamate signaling 
is sensitized, so that it is supportive for recovery to block tonic inhibition or upregulate 
excitatory glutamate transmission (Carmichael, 2012). 
 
1.3 The role of microglia in neuroinflammatory modulation  
Growing evidence has shown that the stroke induced inflammatory responses had 
significant impact on neuronal plasticity during the recovery phase. Following the 
deprivation of energy caused by the blood vessel occlusion, necrotic neuron death could 
induce immune responses by activating and infiltrating inflammatory cells (Wang et al., 
2007). In the acute phase of the ischemic stroke, the first minutes to hours after blockage 
of a vessel, reactive oxygen species (ROS) and proinflammatory mediators including 
cytokines and chemokines are released from injured tissue, which could promote the 
adhesion and migration of circulating leukocytes (Jin et al., 2010). In the subacute phase, 
hours to days after the stroke, the inflammatory response is amplified by increasing the 
infiltration of leukocytes and activation of resident microglial cells that release more 
cytokines and chemokines (Jin et al., 2010). In addition, the excessive production of ROS 
and the over-induced matrix metalloproteases (MMPs) would eventually cause the 
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disruption of BBB, brain edema, neuronal death, and hemorrhagic transformation (Jin et 
al., 2010).  
After the ischemic event, proinflammatory cytokines are released by various types 
of cells including microglia, astrocytes, endothelial cells, and neurons (Candelario-Jalil, 
2009). The significant elevation of chemokines level, which is one type of cytokines that 
modulate leukocyte infiltrations, would increase MMPs’ level (Dirnagl, 2004). The release 
of MMP would impair basal lamina and tight-junction in endothelial cells and thus increase 
the permeability of BBB (Yang et al., 2007). MMP inhibitors were used in animal stroke 
models to reduce infarct size, cell death and BBB damage (Candelario-Jalil, et al., 2009). 
Microglial cells are the resident macrophages of the brain involving in 
neuroinflammatory responses, and the activation of microglia is a major component that 
mediates downstream immune responses after the stroke (Jin et al., 2010). With the post-
stroke energy depletion and neuronal death, the endogenous signaling that inhibits 
inflammatory responses compromises, and leads to microglial activation (Patel et al., 2013). 
This reaction happens within minutes of ischemia onset and then produces 
proinflammatory mediators that could either exacerbate tissue damage or be 
neuroprotective (Jin et al., 2010).  
In a healthy brain, resting microglia can extend and retract their thin ramified 
processes to mediate the microenvironment, control synapse remodeling, and prevent 
accumulation of debris in the central nervous system (CNS) (Patel et al., 2013). The 
morphology of microglia varies depending on their location. Majority of microglia in gray 
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matter were found to be more ramified with radial branches while white matter contained 
less microglia with more longitudinal processes under a healthy condition (Lawson et al., 
1990). However, resident microglial cells would undergo both morphological and 
phenotypic changes after an ischemic stroke (Perego et al., 2011). In previous study using 
permanent middle cerebral artery occlusion (pMCAO) model, the border of lesion showed 
highly ramified cells while the ischemic core had amoeboid cells and hypertrophic soma 
with thick ramifications that were activated (Perego et al., 2011).  
Activated microglia are involved in phagocytosis, cytokine production, antigen 
presentation, and MMPs releasing that weaken BBB integrity, but they can also be 
neuroprotective in some cases (Patel et al., 2013). Microglia was reported to exacerbate 
neurotoxicity by releasing pro-inflammatory cytokines including TNF-!, IL-6, and IL-1", 
but also secrete anti-inflammatory cytokines such as IL-10 and TGF-" that can alleviate 
inflammation (Perego et al., 2011; Taylor & Sansing, 2013). This dual character of 
microglial cells is due to their distinct phenotypes--M1 and M2. After the initial ischemic 
events, M2 microglia are believed to migrate to the infarct area to clean cell debris and 
control the damage within seven days after injury (Hu et al., 2012). However, microglia 
undergo dynamic polarization during this time period that beneficial M2 phenotype 
gradually shifts to detrimental M1 phenotype which results in further neuronal death by 
secreting proinflammatory cytokines including TNF-!, IL-6, and IL-12 (Hu et al., 2012; 
Patel et al., 2013).  The M1 phenotype microglia exacerbates neuronal damage and also 
impair axonal regrowth, while M2 promotes the survival of cortical neurons and the healing 
and repair process after injury (Hu et al., 2012). Another study showed M2 microglia 
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promote axon growth by generating longer axonal projections without causing concurrent 
neurotoxicity (Kigerl et al., 2009). In addition, M2 microglia produce anti-inflammatory 
factors such as IL-10, TGF-", IL-4, and upregulate neurotrophic factors such as insulin 
growth factor (IGF) and brain-derived neurotrophic factor (BDNF) that will be suppressed 
by M1 dominated proinflammatory environment (Patel et al., 2013; Suh et al., 2013). 
Upregulated BDNF can further promote synaptic remodeling and brain recovery by 
inducing spine head filopodia and synapse formation, enhancing the insertion of AMPARs, 
and maintaining the level of postsynaptic NMDA receptor subunits and presynaptic 
VGLUT (Weinhard et al., 2018; Murphy & Corbett, 2009; Parkhurst et al., 2013). 
 
1.4 The role of microglia in synaptic plasticity and remodeling 
Brain plasticity is based on the dynamic synaptic remodeling mediated by 
alternating neuronal activity, which can remodel the spines from multiple aspects including 
size, shape and motility (Tremblay & Majewska, 2011). By directly contacting synaptic 
elements with their processes, microglia can be involved in synaptic plasticity such as 
regulating dendritic spine remodeling (Tremblay & Majewska, 2011). Microglia are found 
to actively interact with dendritic spines, axon terminals, perisynaptic astrocytic processes 
which indicates a direct communication between microglia and synapses by the exchange 
through membrane (Tremblay & Majewska, 2011). In addition, microglia can mediate 
extracellular matrix (ECM) by secreting extracellular proteases (Tremblay & Majewska, 
2011). ECM plays an important role in both synaptic structural plasticity and cell 
excitability. They interact with dendritic spines to promote stabilization of dendritic 
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protrusions and maturation, while regulate the actin cytoskeleton to maintain synaptic 
structures that are closely associated with synapse functions (Tremblay & Majewska, 2011). 
In addition, ECM molecules are shown to regulate the glutamate excitatory signaling by 
influencing Ca2+ homeostasis and therefore mediate NMDA receptors and other 
downstream signal pathways for LTP or LTD formation (Dityatev & Sonderegger, 2010). 
Other enzymes that depend on Ca2+ activation can further alternate actin cytoskeleton 
(Dityatev & Sonderegger, 2010). 
Microglia are broadly involved in synaptic plasticity. Previous study showed 
microglia induced spine head filopodia formation that filopodia extended toward the 
microglia process to form new spine-bouton contacts (Weinhard et al., 2018). On the other 
hand, microglia are phagocytic cells that engulf not only neuronal debris but also 
presynaptic and postsynaptic elements including axonal terminals and dendritic spines in 
the process of circuit refinement in CNS, which is suggested to involve in synaptic pruning 
and circuit maturation (Wu et al., 2015; Paolicelli et al., 2011; Schafer et al., 2012). The 
phagocytosis of microglia can be neuroprotective by attenuating inflammation (Patel et al., 
2013). Microglia phagocytose damaged tissue, cellular debris and other harmful substances 
to reduce the detrimental effects of inflammation, re-establish tissue homeostasis, and 
promote tissue repair processes (Patel et al., 2013). However, phagocytosis may be over 
elicited by improper signal and lead to neuronal cell death by phagocytose synapses and 
neutrites of live neurons (Brown & Neher, 2014).   
 
1.5 Therapeutics targeting inflammation after cortical injury  
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1.5.1 Mesenchymal-derived exosomes as a therapeutic to reduce inflammation and 
promote restoration after cortical injury  
Spontaneous brain plasticity during the recovery phase following brain injury 
involves multiple pathways and various components provides us diverse therapeutic targets 
for drug interventions. Intravenous administration of tissue plasminogen activator (tPA) as 
a thrombolytic therapy is the only FDA-approved therapy for ischemic stroke. However, it 
can only benefit patients within a narrow therapeutic window (three hours) after the onset 
of stroke and also have other potential risks such as inducing cell death in neurovascular 
units (Wang et al., 2004). Recent research has been exploring other possible treatments 
with less limitations. Cell based therapies have gained growing attention recently due to its 
neurorestorative effects in post-stroke recovery by promoting brain plasticity and synaptic 
remodeling (Orczykowski et al., 2019).  In previous studies with rodent models, animals 
treated with human umbilical tissue-derived cells (hUTC) showed functional and 
behavioral improvements, and had increasing cell proliferation, vascularity and 
synaptogenesis (Jiang et al., 2012; Yang et al., 2012). Studies with non-human primate 
models also suggested hUTC as an effective treatment that promotes the reorganization of 
the ventral premotor cortex and enhances behavioral test results in motor recovery 
(Orczykowski et al., 2019; Moore et al., 2013). Injection of human umbilical cord 
multipotent mesenchymal stromal cells (UC-MSC) are found to promote functional 
recovery in a rat model after stroke by reducing brain injury volume, increasing levels of 
angiogenic factors, and enhancing learning and memory abilities (Liao et al., 2009). 
Multipotent mesenchymal stromal cells (MSCs) consisting of mesenchymal stem and 
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progenitor cells can be derived from bone marrow, fat tissue, fetal cord blood and 
peripheral blood (Ho et al., 2008).  
Exosomes that originate from endosomes are small membrane vesicles that can be 
derived from MSCs (Xin et al., 2013). Containing various biomaterials including proteins, 
DNAs, RNAs and miRNAs, exosomes play an important role in the communication 
between cells that contributes to brain remodeling by transferring cargo from source cells 
to target cells (Zhang et al., 2017; Zhang & Chopp, 2016). Intravenously administered cell-
free exosomes in a rat model with traumatic brain injury are shown to enhance spatial 
learning and sensorimotor functional recovery, increase vascular density, angiogenesis, 
and neurogenesis, promote distal axon growth by increasing both length and speed, and 
reduce brain inflammation (Zhang et al., 2015; Zhang et al., 2017). The anti-inflammatory 
effect of exosomes treatment is also found in rats and monkey models of stroke (Go et al., 
2019; Zhang et al., 2019). 
1.5.2 Dietary curcumin: an anti-inflammatory and antioxidant therapeutic for cortical 
injury 
Considering the importance and complexity of the brain inflammatory responses 
during the recovery phase, anti-inflammation is another potential target for therapeutic 
strategy. Curcumin has been suggested to be an anti-inflammatory and antioxidant 
substance that can reduce oxidative damage and cognitive deficits (Wu et al., 2006). In a 
previous study using a rat model with middle cerebral artery occlusion (MCAO), curcumin 
treated group was demonstrated to reduce proinflammatory cytokines including TNF-!, 
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IL-6, and IL-12p70 without showing cytotoxicity to microglia (Liu et al., 2017). In addition, 
3-day curcumin treatment resulted in elevating beneficial M2 microglia phenotype, 
reducing M1, and also decreased infarct volumes and improved sensorimotor functions 
(Liu et al., 2017). In an earlier study, intraperitoneally injected curcumin was shown to 
promote nerve regeneration and accelerate motor recovery (Ma et al., 2013).  
Regarding the therapeutic benefits of curcumin and anti-inflammatory properties, 
we are investigating the effects of dietary curcumin treatment in the recovery from cortical 
injury, specifically on the synaptic properties, microglial activity and neuron excitability. 
  
1.6 Purpose and hypothesis of the current study 
Regarding the worldwide rate of occurrence of stroke and the limited treatments for 
post-stroke recovery, the present study investigated and compared the therapeutic effects 
of mesenchymal-derived exosomes and dietary curcumin on the recovery from cortical 
injury in the rhesus monkey. The cellular mechanisms of each treatment were explored by 
assessing cell excitability, the density of excitatory synapses, and brain inflammatory 
responses in terms of microglial activity in brain tissue from monkeys that received one of 
the two treatments.  
This project focused on the in excitatory synapses and microglial activity that 
occurred following cortical injury and they changed following treatment with either MSCs-
exosomes or curcumin. In order to assess the synaptic components, we used 
immunohistochemistry methods to label and quantify excitatory synapse markers 
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(VGLUTs and GluRs), as well markers of microglia (Iba-1/P2RY12). In addition, 
intracellular filling was applied on pyramidal neurons in the perilesional area for the 





2.1 Animals and protocols 
A total of 16 Rhesus monkeys (Macaca mulatta), ranging from 16 to 21 years old 
(12 females, 4 males) were acquired from a private vendor (WorldWide Primates, Inc.). 
All monkeys were prescreened to ensure that they did not have brain abnormality or any 
history of neurological diseases, chronic diseases, diabetes, or malnutrition (Orczykowski 
et al., 2019). They were housed in the Animal Science Center of Boston University Medical 
Campus under a 12-hour light/dark cycle. All experimental procedures using animals were 
approved by the Institutional Animal Care and Use Committee (IACUC) at Boston 
University School of Medicine, and performed in accordance with the Guide for the Care 
and Use of Laboratory Animals from the NIH’s Office of Laboratory Animal Welfare.  
All monkeys were trained on a fine motor task, the Hand Dexterity Task, for a total 
of five weeks (Moore et al., 2019). They were randomly assigned into exosome treated 
(n=5), curcumin treated (n=2), vehicle treated (n=6), and non-lesion control groups (n=3). 
Surgery to induce cortical injury in the hand representation of primary motor cortex (M1) 
was conducted for all groups except the non-lesion control group. The exosome treated 
group received 4×1011 exosomes/kg intravenously twice, once at 24 hours and again at 14 
days after the surgery. Monkeys in the curcumin treated group received daily dietary 
curcumin with an oral dose of 500 mg throughout the 12 week recovery period. Monkeys 
in the vehicle control group received intravenous PBS at similar volume as the exosome 
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treatment. Then, the motor tasks were resumed for 12 weeks to assess the degree of 
recovery. 
 
2.2 Surgical lesion of M1 hand representation 
Monkeys in exosome-treated, curcumin-treated, and vehicle-treated groups all 
receive surgery that makes a lesion on the hemisphere controlling the dominant hand, and 
the lesion is limited to the hand representative area of the primary motor cortex (M1). To 
determine the precise area of M1, the precentral gyrus is electrophysiologically mapped 
with a small silver ball surface electrode (Moore et al., 2019). Then, a small glass suction 
pipette is inserted through an incision in the pia, and bluntly separates the penetrating 
arterioles from the underlying cortex (Moore et al., 2019). By disrupting the blood supply, 
this procedure produces an ischemic lesion on the gray matter while preserving underlying 
white matter (Moore et al., 2013).  
 
2.3 Perfusion and tissue preparation 
Monkeys are sedated with ketamine (10 mg/kg), anesthetized with sodium 
pentobarbital (25mg/kg IV), and euthanized by exsanguination during transcardial 
perfusion-fixation of the brain (Go et al., 2019). Cold Krebs-Heinsleit buffer (4°C, pH7.4) 
was used for collecting fresh tissue biopsies just ventral to the lesion for in vitro whole-cell 
patch clamp and intracellular filling (Medalla and Luebke, 2015), and then 4L of 4% 
paraformaldehyde (30°C, pH7.4) was used to fix the brain (Go et al., 2019). Removed 
 
17 
brains were cryoprotected in a solution with 0.1M phosphate buffer (PB), 10% glycerol, 
and 2% DMSO followed by buffer with 2% DMSO and 20% glycerol (Go et al., 2019). 
Then, brains were flash-frozen in -75°C isopentane and stored at -80°C before being cut. 
Brains were cut on a microtome into interrupted series containing eight series of 
30µm sections and one series of 60µm sections. The 30µm tissues were kept in the 
phosphate buffer with 15% glycerol and stored in -80°C for later processing, and half of 
the 60µm sections were immediately mounted and stained with thionin for lesion 
reconstruction. 
 
2.4 Microglia and VGLUTs immunohistochemistry on serial sections through the 
lesion 
Microglia-specific labels, P2RY12 and Iba-1, were used as the markers for 
microglia expression, and VGLUT1 and 2 were used as presynaptic markers for excitatory 
glutamatergic synapses. All the sections stayed in 50mM Glycine for 1 hour and were 
washed with 0.01M PBS. Antigen retrieval was performed in 10mM citrate buffer (pH=8.5) 
at 60°C to 65°C for 20 minutes. After the antigen retrieval, the sections were washed with 
0.01M PBS again, and then were incubated in the pre-block solution (5% bovine serum 
albumin (BSA), 5% normal donkey serum (NDS), 0.2% Triton X-100 in 0.01M PBS) for 
1 hour at room temperature. After the pre-block, brain sections were incubated with 
primary antibodies to P2RY12 combined with Iba-1 (rabbit 1:300) VGLUT1 (goat 1:1000), 
and VGLUT2 (guinea pig 1:1000) in carrier solution (0.2% bovine serum albumin (BSA), 
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1% normal donkey serum (NDS), 0.1% Triton X-100 in 0.1M PB) at 4 °C over 2 nights. 
Sections were microwaved by PELCO Biowave (TED PELLA Inc, CA) twice at 40 °C, 
150 watts for 10 minutes during the incubation. After 48-h incubation, brain sections were 
washed with PBS and incubated with secondary antibodies in carrier solution for 24 hours 
at 4 °C. Following the secondary antibody incubation, sections stayed another 24 hours in 
Streptavidin-635 with carrier solution. Autofluorescence reduction was performed by 
incubating brain sections in 10mM cupric sulfate for 30 minutes. Then, the sections were 
washed with dH2O to wash off excessive cupric sulfate and stored in PB, and finally 
mounted with the Prolong antifade mounting medium. 
 
2.5 Intracellular cell filling during in-vitro whole cell patch clamp recording and thick 
slice IHC 
To label pyramidal neurons and study dendrites and spines, 300-µm-thick coronal 
brain slices were placed into room temperature oxygenated (95% O2, 5% CO2) Ringer’s 
solution. After 1-hour equilibration period, individual brain slices were placed into 
recording chambers (Harvard Apparatus) mounted on the stages of Nikon E600 infrared-
differential interference contrast microscopes (Micro Video Instruments) (Medalla & 
Luebke, 2015).  
Then, in-vitro whole cell patch clamp experiments were performed on the layer 3 
pyramidal neurons in the perilesional region. Cells were visualized under the infrared-
differential interference contrast optics, and electrodes were fabricated on a horizontal 
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Flaming and Brown micropipette puller (model P-87, Sutter Instruments) (Medalla & 
Luebke, 2015). Potassium methanesulfonate-based solution (concentrations in mM: 122 
KCH3SO3, 2 MgCl2, 5 EGTA, 10 Na- HEPES, 1% biocytin, pH 7.4; Sigma-Aldrich) was 
used as internal solution in electrodes with resistances of 3– 6 M in the external Ringer’s 
solution (Medalla & Luebke, 2015). Data was acquired using EPC-9 or EPC-10 patch-
clamp amplifiers (HEKA Elektronik) and PatchMaster acquisition software (HEKA 
Elektronik) (Medalla & Luebke, 2015). Access resistance was monitored throughout the 
duration of all experiments. All experiments were conducted at room temperature. 
After recording, slices were immersion-fixed in 4% PFA for 2 days. Filled cells 
were visualized by incubating slices in 1% Triton-X in 0.1M PB for 2 hours at room 
temperature, then in Streptavidin Alexa-488 probe for 2 days (1:800, 4°C). To assess 
microglia-spine appositions, slices with filled cells were then processed for 
immunolabeling of microglia as described (Medalla and Luebke, 2015). Slices were 
incubated in primary antibody for Iba-1/P2RY12 (rabbit 1:300) to label microglia, as 
described above (in section 2.4), for over 7 days at 4°C. After rinsing, slices were incubated 
in anti-rabbit IgG secondary antibody conjugated to Alexa 546 for over 4 days at 4°C. Each 
incubation had six to eight 10-min microwave sessions to assist with antibody penetration.  
 
2.6 Confocal scanning and particle analysis 
Perilesional area of grey matter in each section was imaged by a Leica TCS SPE 
laser scanning confocal microscope with 3 laser lines: 488 nm, 546 nm, and 647 nm. For 
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each brain section, four images were scanned in perilesional grey matter with a 40x oil 
objective lens at a resolution of 0.134*0.134*0.5µm. The filled neurons were imaged twice 
by the microscope with 488 nm laser under both 40x and 60x oil objective lens. Each 
confocal image was deconvolved and converted to 8-bit images using AutoQuant (Media 
Cybernetics). 
The density of each channel (VGLUT1, VGLUT2, Iba-1/P2RY12) was analyzed 
in Image J. The detective threshold was set by Renyi method. One threshold was used for 
one channel through four images of one animal. Parameters were calculated in Image J 
including total area, average size, percentage area and mean gray value. The colocalization 
of VGLUT1-microglia, and VGLUT2-microglia were analyzed by an Image J plugin, 
EzColocalization (Stauffer et al., 2018). For colocalization analysis, threshold overlap 
score (TOS), Pearson’s correlation coefficient (PCC), and Mander’s colocalization 
coefficient of channel 1 and 2 (M1 & M2) were calculated. 
 
2.7 Neuron reconstruction of filled pyramidal neurons and microglia apposition 
 Pyramidal neurons in layer 3 in the perilesional area were intracellularly filled and 
processed for IHC to label microglial. One apical dendrite and one basal dendrite were 
chosen from each filled pyramidal cell and tile scanned to follow from base to tip, using 
dual channel confocal microscopy (as above). Confocal scanned images were montaged in 
Neurolucida (v11.01, Microbrightfield). All the dendritic spines were marked with their 
type (thin, mushroom, filopodia, stubby). The types of potential microglia interactions with 
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filled neurons were categorized as follows: microglia apposition on cell body, apposition 
on shaft, apposition on spine, proximal to cell body, proximal to shaft, proximal to spine. 
Appositions require overlap of saturated signal from the two channels, while proximity was 
identified as adjacent signal from the two channels. The traced neurons with markers of 
microglial apposition were analyzed in Neuroexplorer (v11.01, Microbrightfield). Basic 
information was calculated, including total length of dendrites, the surface area of cell body, 
number of spines in different types, number of appositions.   
 
2.8 Statistical analysis 
Particle analysis results from ImageJ were processed using MATLAB (MathWorks, 
Natick, MA) to calculate the average of each parameter (total area, average size, percentage 
area, mean gray value) for each section. Group means and standard deviations were 
calculated. Differences of each parameter between groups were assessed by performing a 
Student’s t test or repeated-measures ANOVA, with a significance level of 0.05. 




3.1 VGLUTs density was modified by exosome treatment 
Overall, both VGLUT1 and 2 showed similar patterns of changing in three groups 
that the non-lesion control group had more VGLUTs and smaller particle size as compared 
with the other two lesioned groups (Figure 1 & 2). The control group had more VGLUTs 
density as compared with lesioned groups (Figure 1a & 2a), especially VGLUT2 was 
significantly higher in the control group (Figure 2a: p<0.05). The control group also had 
smaller VGLUTs average size, and the particle size in the control group was significantly 
lower as compared with the exosome treated group (Figure 1b: p<0.01; Figure 2c: p<0.05). 
There was no significant difference in mean gray value. The results indicated that the lesion 
in the primary motor cortex caused a loss of excitatory synapses in the perilesional area in 
terms of lower level of VGLUTs in groups with lesion.  
The exosome treated group showed an increase of VGLUTs density as compared 
to the vehicle treated group, but the difference was only significant in VGLUT2 (Figure 
2b: p<0.05). In addition, the particle size of VGLUTs was generally bigger in the exosome 
treated group, and again, the difference was only significant in VGLUT1 average size 
(Figure 1b: p<0.05). The results suggested that the exosome treatment increased the 




Figure 1: The area fraction (µm2), average size(µm2), and mean gray value (µm2) of 
VGLUT1. a: The control group had a non-significantly higher value in %area as compared 
with the other two groups; b: the control group had significantly smaller particle size as 
compared with the exosome treated group (p<0.01), and non-significant smaller size than 
vehicle treated group; c: no significant difference was reported in the mean gray values 





Figure 2: The area fraction (µm2), average size (µm2) and mean gray value (µm2) of 
VGLUT2. a: The control group showed significantly higher VGLUT2 %area as compared 
with the other two groups (p<0.05); b: the exosome treated group showed increasing 
VGLUT2 %area as compared with the vehicle treated group; c: the control group had 
significantly smaller particle size as compared with the exosome treated group (p<0.05), 
and non-significant smaller size than vehicle treated group; d: no significant difference 
was reported in the mean gray values among 3 groups. 
 
3.2 Lesion induced microglia activation 
 No significant difference was reported in microglia density of three groups (Figure 
3a). The average particle size of microglia in the non-lesion control group was significantly 
smaller as compared with the other two groups (p<0.05). The mean gray value was 
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significantly higher in the control group as compared with the exosome treated group 
(Figure 3c: p<0.01). There was no significant difference between vehicle treated and 
exosome treated groups. The increase in microglia size indicated a higher microglia activity 
in groups with lesions (vehicle and exosome treated groups). 
 
Figure 3: The area fraction (µm2), average size (µm2) and mean gray value (µm2) of 
microglia markers (Iba-1 & P2RY12-positive). a: There was no significant difference 
in %area among three groups; b: the control group had significantly smaller microglia size 
as compared with the other 2 groups (p<0.05); c: the mean gray values were only 
significantly different between control and exosome treated group (p<0.01). 
 
3.3 Exosome treatment modulated the interaction between microglia and VGLUTs 
 
26 
Figure 4 showed examples of immuno-stained VGLUT1 (green channel), VGLUT2 
(red channel), and microglia (blue channel) in terms of Iba-1 or P2RY12 positive in either 
non-lesion control animal (Figure 4a) or animal with lesion (Figure 4b).  
In general, the non-lesion control group showed less colocalization between 
VGLUTs and microglia, and the results were more significant in VGLUT1-microglia 
colocalization. Though there was no significant difference in TOS linear values among 
three groups in VGLUT1-microglia colocalization, the control group had a relative lower 
TOS linear value (Figure 5a). The Pearson's correlation coefficient (PCC) of the non-lesion 
control group was significantly lower than the other 2 groups (Figure 5b: control vs vehicle: 
p<0.01; control vs exosome: p<0.05). In M1 and M2 of VGLUT1-microglia colocalization, 
there was a non-significant trend of lower value in the control group as compared to the 
other 2 groups (Figure 5c & d). There was no significant difference in most results of the 
VGLUT2-microglia colocalization parameters except PCC values. The PCC value in the 
non-lesion control group was significantly lower as compared to the vehicle treated group 
(Figure 6b: p<0.05).  
Though there was no significant difference between vehicle and exosome treated 
group in all colocalization parameters of VGLUT1-microglia or VGLUT2-microglia, there 
was a trend that exosome treated group had relative lower value of colocalization 
parameters as compared with vehicle group (Figure 5 & 6). 
Overall, these results implied that groups with lesion (vehicle & exosome) had more 
VGLUT-microglia interaction in terms of higher value in colocalization parameters as 
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compared to the non-lesion control group. In addition, the exosome treated group had a 
relatively lower VGLUT-microglia interaction as compared with the vehicle group, which 
suggested that exosome treatment might help the recovery by inhibiting microglial activity 
on excitatory synapses. 
  
Figure 4: Confocal images of immuno-stained VGLUT1 (green channel), VGLUT2 (red 
channel), microglia (blue channel; Iba-1/P2RY12-positive) in an animal with lesion (a), 
and in a non-lesion control animal (b). A colocalization was considered when 2 channels 




Figure 5: The colocalization parameters of VGLUT1-microglia. a: control group had a 
non-significantly lower TOS linear value as compared with the other 2 groups, and 
exosome had a non-significantly lower TOS linear value as compared with vehicle treated 
group; b: PCC value was significantly lower in control group as compared with the other 
2 groups (control vs vehicle: p<0.01; control vs exosome: p<0.05), and exosome had a non-
significantly lower PCC value as compared with vehicle treated group; c: control group 
had a non-significantly lower M1 value as compared with the other 2 groups, and exosome 
had a non-significantly lower M1 value as compared with vehicle treated group; d: vehicle 




Figure 6: The colocalization parameters of VGLUT2-microglia. a: no significant 
difference in TOS linear value was reported; b: PCC value was lower in control group as 
compared with the other 2 groups, but the difference was only significant between control 
and vehicle group (p<0.05); c & d: no significant difference in M1 or M2 was reported, 
but exosome had a non-significant trend of lower M1 and M2 values as compared with 
vehicle treated group. 
 
3.4 The exosome treatment reduced microglia apposition on dendrites 
Figure 7 was an example of the microglia apposition on dendritic spines. As shown 
in figure 8a and 8b, the vehicle treated group had significantly higher rate of apical 
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dendritic spines and shaft that was apposed with microglia as compared to the exosome 
treated group (p<0.05). Though there was no significant difference between the control 
group and the other 2, the control group had relatively less microglia apposition on apical 
dendrite as compared to the vehicle group (Figure 5a & b). There was no microglia 
apposition found on basal dendritic spines in the control group (Figure 5c). No significant 
difference was found in the density of microglia apposition on the basal dendritic shaft 
among 3 groups (Figure 5d).  
Similar results were found in Figure 9-11. The vehicle group had more total 
microglia apposition as compared with the control and exosome treated group. Our results 
indicated that the lesion induced an increase in microglia actions on spines and dendritic 
shaft, and the exosome treatment helped to reduce the microglia interaction with apical 
dendrites but not basal dendrites. These results were consistent with our VGLUT-microglia 
colocalization data (Figure 5 & 6).  
 Figure 7: Microglia (red) apposition on spines (green). 
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Figure 8: The percentage of apical/basal dendritic spines that were apposed with microglia 
(a & c) and the density of microglia apposition on apical/basal dendrite shaft (b & d). a: as 
compared to exosome treated group, vehicle group had significantly more apical dendritic 
spines apposed with microglia (p<0.05); b: the density of microglia apposition on apical 
shaft in vehicle group was significantly higher as compared with exosome treated group 
(p<0.05); c: control group had zero apposition on basal spines; d: no significant difference 
was reported in the density of microglia apposition on basal shaft among 3 groups. 
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Figure 9: The total apposition of microglia along the apical/basal dendrite. a: vehicle 
group had more microglia interaction with apical dendrite as compared with the other 2 
groups; b: no significant difference in microglia interaction with basal dendrite was 
reported among 3 groups. 
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Figure 10: The density of microglia apposition or proximation on apical spines/shaft. a & 
b: vehicle group had more microglia apposition on apical spines and shaft as compared to 
the other 2 groups; c: no microglia apposition on the apical dendrites in control group; d: 




Figure 11: The density of microglia apposition or proximation on basal spines/shaft. a: 
vehicle and exosome treated groups had more microglia apposition on basal spines; b & c: 
no significant difference was found; d: vehicle and exosome treated groups had more 
microglia proximal to basal shaft. 
 
3.5 The effect of exosome treatment on GluR2/3 
Figure 12 was an example of immuno-stained GluR2/3 in the blue channel. Vehicle 
group had a non-significantly lower level of GluR2/3 density as compared with the control 
and exosome treated group (Figure 13a). There was no significant difference in GluR2/3 
particle size among 3 groups (Figure 13b). The mean gray value was significantly lower in 
the control group as compared with the exosome treated group (Figure 13c). 
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This result was consistent with the results of presynaptic VGLUTs (Figure 1 & 2). 
The lesion induced a reduction in excitatory synapses, and the exosome treatment helped 
increase the density of excitatory synapses during recovery.  
 
Figure 12: confocal images of immuno-stained GluR2/3 (blue).  
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Figure 13: The area fraction (µm2), average size(µm2) and mean gray value (µm2) of 
GluR2/3. a: vehicle treated group had a non-significant lower value of GluR2/3 %area as 
compared with control and exosome treated group; b: no significant difference was found 
in GluR2/3 average size among 3 groups; c: the mean gray values were significantly 
different between control and exosome treated group (p<0.01). 
3.6 Curcumin treatment does not reverse excitatory synaptic loss 
Similar to the results above, groups with lesion in M1 (vehicle and curcumin treated 
groups) showed significantly lower density in both VGLUT1 and 2 as compared with the 
non-lesion control group (Figure 14a & c: p<0.01). The result in the size of VGLUT1 and 
2 was inconsistent with previous results. Groups with lesions had smaller particle size of 
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VGLUTs instead of larger size as compared with the non-lesion control (Figure 14b & d). 
The curcumin treated group did not show higher density of VGLUTs as compared with the 
vehicle group. Instead, there was even less VGLUT1 in the curcumin group as compared 
with the other 2 groups (Figure 14a: p<0.01).  
These results showed similar lesion-induced synaptic loss as the results above 
(Figure 1a & 2a). However, no evidence showed that the curcumin treatment could reverse 
the synaptic loss as the exosome treatment did.  
Figure 14: The area fraction (µm2), average size (µm2) of VGLUT1 and 2. a: The 
curcumin treated group had significantly lower VGLUT1 %area as compared with the 
other two groups (p<0.01); b: the curcumin group had smaller VGLUT1 particle size as 
compared with the control group (p<0.05) and the vehicle group (p<0.01); c: the control 
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group had significantly more VGLUT2 as compared with the other 2 groups (p<0.01); d: 
the control group had significantly larger size of VGLUT2 as compared with the other 2 
groups (p<0.01). 
3.7 Curcumin treatment lessened lesion-related increase in average size of microglia 
No significant difference was found in the density of microglia among 3 groups 
(Figure 15a). The vehicle treated group showed greater microglia size as compared with 
the non-lesion control group (Figure 15b: p<0.01). These results were similar to previous 
results (Figure 3).   
No significant difference in the size of microglia was found between the curcumin 
group and the non-lesion control group (Figure 15b). This result indicated that the 
curcumin treatment dampened the increase the size of microglia associated with lesion, 
which implied that the curcumin treatment had impact on lesion related microglia activity. 
Figure 15: The area fraction (µm2), average size (µm2) of microglia. a: no significant 
difference was found in microglia %area among 3 groups; b: the vehicle treated group had 
greater microglia size as compared with the control group (p<0.01). 
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3.8 Curcumin treatment effect on lesion-related VGLUT-microglia interaction 
Figure 16 and 17 showed the comparison of VGLUTs-microglia colocalization 
parameters. The non-lesion control group had significantly lower TOS linear, M1 and M2 
value in VGLUT1-microglia colocalization as compared with the other 2 groups with 
lesion (Figure 16a, c & d: p<0.01). No significant difference was found in these values 
between the vehicle and the curcumin treated group. The vehicle group had lower PCC 
value in VGLUT1-microglia colocalization as compared with both control and curcumin 
group (Figure 16b: p<0.05).  
The non-lesion control group had significantly lower TOS linear, M1 and M2 value 
in VGLUT2-microglia colocalization as compared with the vehicle group (Figure 17a, c & 
d: p<0.05). No significant difference was reported in these values between the control and 
curcumin group. No significant difference in PCC value among all 3 groups (Figure 17b). 
These results indicated that the curcumin treatment did not change VGLUT1-




Figure 16: The colocalization parameters of VGLUT1-microglia. a: the control group had 
significantly lower TOS linear value as compared with the other 2 groups (p<0.01); no 
significant difference was reported between vehicle and curcumin treated group; b: both 
control group and curcumin group had significantly higher PCC value as compared with 
the vehicle treated group (p<0.05); c & d: control group had significantly lower M1 and 




Figure 17: The colocalization parameters of VGLUT2-microglia. a: the vehicle treated 
group had greater TOS linear value (p<0.05) as compared with the control group; b: no 
significant difference was reported; c & d: the vehicle group had higher M1 and M2 values 





The present study investigated the changes in synaptic and microglia markers 
following cortical injury in primary motor cortex following treatment with either MSC-
exosomes or curcumin, both of which are known to modulate inflammation (Go et al., 2019; 
Liu et al., 2017). We analyzed and compared presynaptic and postsynaptic components in 
different conditions and also the interaction between microglia and synapses. Overall, our 
results indicated that the lesion in primary motor cortex causes a loss of excitatory synapses 
in terms of the reduction in both presynaptic vesicular glutamate transporters (VGLUT1 
and 2) and postsynaptic glutamate receptor subunits (GluR2/3). In addition, there was no 
significant change in the density of microglial marker Iba-1/P2RY12 among the groups. 
These results suggested that the synaptic loss due to injury might be due to elevated 
activation of microglia and its interactions with dendritic spines instead of a greater density 
of microglia in the perilesional area. The exosome treatment was shown to lessen some 
synaptic loss by reducing the microglia interactions with spines and increasing the particle 
size of VGLUT1 and 2, suggestive of plasticity. In contrast, curcumin treatment had no 
effect of synapse and microglia markers. 
 
4.1 Cortical injury induced microglia activation causes synaptic loss 
In both vehicle and exosome treated groups, we found significant reduction in the 
density of VGLUT1 and 2 in the perilesional area as compared to the non-lesion control 
group (Figure 1 & 2). This reduction indicated a severe loss of excitatory synapses caused 
by cortical injury, which was consistent with the results in previous studies that ischemia 
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event could lead to loss of spines and dendritic structures (citation). We also found a 
significant difference in microglia average size between the control group and lesioned 
groups (Figure 3), which implied a difference in microglia activation. The results of 
colocalization between VGLUTs and microglia and the microglia apposition data from 
reconstructions of dendrites helped us confirm that there was a significant difference in 
microglia activity between non-lesion and lesion groups.  
Synaptic loss is strongly correlated with neuroinflammation and microglial activity. 
During neuroinflammatory modulation, activated microglia release proinflammatory 
cytokines such as TNF-α and IL-1", which can regulate gene expression of arachidonic 
acid and have further impact on signal transduction, apoptosis, neuronal activity, etc (Rao 
et al., 2012). Neuroinflammation has been suggested to closely correlate with the post-
injury excitotoxicity. The activated microglia reuptake can block the reuptake of glutamate 
by releasing nitric oxide, and the excessive glutamate in synaptic cleft results in 
overactivation of NMDA receptor, which will further upregulate proinflammatory 
cytokines (Rao et al., 2012). The signal cascade that follows the neuroinflammation was 
found to upregulate the pro-apoptosis markers and reduce synaptic protein (Rao et al., 
2012).   
Interestingly, in the present study we found that the change in GluR2/3 between 
non-lesion and lesion groups was not as at the same magnitude as the changes in VGLUTs 
(Figure 13, Figure 1 & 2). In a previous study on microglia-synaptic interaction, microglia 
trogocytosis was only found on presynaptic structures (boutons and axons) but not on 
postsynaptic structures (Weinhard et al., 2018). However, in an earlier study, microglia 
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were found to decrease the expression of AMPA receptor 1 (GluA1) as well as the AMPA-
mediated mEPSC frequency (Ji et al., 2013). Therefore, by integrating results from both 
studies as well as our results, microglia can mediate presynaptic structure and postsynaptic 
structures with different mechanisms. While microglia directly engulf the presynaptic 
structures, the microglia modulation on postsynaptic receptors was suggested to be more 
indirect by regulating glutamate transport and release of cytokines such as TNF-! (Ji et al., 
2013). Therefore, with a more complicated mechanism and signal cascade of microglial 
regulation on postsynaptic structures, it is reasonable that the changes in GluR2/3 were less 
significant as compared with the changes in presynaptic VGLUTs. 
 
4.2 Exosome treatment increases synapse density by mediating neuroinflammatory 
responses 
Regarding the crucial role of microglia and neuroinflammatory modulation in brain 
health and recovery, previous studies have suggested microglia as an effective therapeutic 
target. For example, minocycline as an anti-inflammatory drug was found to be 
neuroprotective in different animal models of neurodegenerative disorders by inhibiting 
microglia activation (Du et al., 2017). In our previous work, exosome treatment was shown 
to significantly improve fine motor recovery after cortical injury by reducing 
neuroinflammation and switching microglia from proinflammatory to anti-inflammatory 
status in aged monkeys (Moore et al., 2019; Go et al., 2019). In Go et al. 2019, exosome 
treatment was found to shift microglia towards homeostatic status, whereas microglia in 
 
45 
the vehicle group produced chronic neuroinflammation that impeded recovery (Go et al., 
2019). In addition, it was suggested that the changes of microglia morphology were crucial 
in the exosome treatment. It was found that the morphology of microglia was significantly 
correlated with motor recovery that a higher percentage of ramified microglia was 
associated with a more rapid recovery (Go et al., 2019).  
The morphology of microglia is closely associated with their function. Resting and 
homeostatic microglia in a healthy brain are known as surveying microglia with ramified 
processes extending and retracting, and they work as anti-inflammatory cells in this status 
(Patel et al., 2013). In the injured brain area, activated microglia with 
hypertrophic/amoeboid shape start to release proinflammatory cytokines (Patel et al., 
2013).  
In the present study, our results indicated that the synapse-microglia interaction 
could be modulated by exosome treatment. We found increased density of VGLUTs along 
with a decreasing synapse-microglia interaction in the exosome treated group, indicating 
that the exosome treatment increased the number of excitatory synapses by reducing 
microglia actions. The exosome treated group showed similar level of microglia actions on 
dendritic spines as the non-lesion control group, whereas the vehicle treated group showed 
a much higher microglia interaction and colocalization with spines or excitatory synapses.  
As previous study suggested, brain injury activated the innate immune system, 
which produced inflammatory response for protective purpose to remove apoptotic cells 
and cellular debris (Skaper et al., 2014). However, this neuroinflammatory reaction can be 
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over activated and therefore become destructive to synapses. Regarding the results from 
the previous works combining with our results, we can conclude that hypertrophic 
microglia in the ischemic area may phagocytose presynaptic boutons, that have been 
damaged due to injury. This would likely exacerbate local inflammation, which therefore 
impedes the recovery and sprouting of new synaptic connections. The exosome treatment 
following the injury, on the other hand, improves the recovery by switching microglia to 
homeostatic status with anti-inflammatory function by promoting release of growth factors 
and potentially reducing synapse-microglia interaction (i.e., phagocytosis) (Go et al., 2019; 
Patel et al., 2013).  
Our previous study showed that ramified:hypertrophic microglia ratio was 
negatively correlated with synapse-microglia interaction (Go et al., 2019). Both 
homeostatic/ramified and hypertrophic microglia interact with spines and boutons but 
serve different functions. Homeostatic microglia promote release of anti-inflammatory 
signals and growth factors that promote synapse growth, while hypertrophic microglia can 
engulf and phagocytose damaged synaptic fragments (Patel et al., 2013). Part of the 
molecular mechanisms of microglia-synapse interaction involves complement system 
signal cascade. A crucial molecule, complement component C3, is associated with clearing 
pathogens, cell debris, and cellular structures by activating phagocytosis cells such as 
microglia (Stephan et al., 2012). Further research on specific mechanisms and markers that 
mediated microglia interaction with synapses need to be done.  
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Mesenchymal derived exosomes contain multiple types of proteins and also 
biologically active molecules including RNAs, DNAs, miRNAs, etc. (Chen & Chopp, 
2018). Due to the complexity in their composition, the mechanism of their effects on 
microglia and neuronal synaptic connections is not clear yet. More molecular signaling 
pathways may be involved as part of the therapeutic process and more studies need to be 
done to uncover the mechanism. 
 
4.3 Curcumin treatment modulates microglial activity but not synaptic connection  
We have demonstrated that exosome treatment had therapeutic benefit on motor 
recovery and was found to switch microglia from proinflammatory to anti-inflammatory 
status (Moore et al., 2019; Go et al., 2019). These results indicate that anti-inflammatory 
processes are a potential therapeutic target for stroke recovery, so we postulated that other 
substances with anti-inflammatory function might also show similar effects as exosome 
treatment. Curcumin is known for its anti-inflammatory and antioxidant properties. 
Previous studies demonstrated that both dietary and intravenously injected curcumin 
reduced post-injury inflammation and benefited the recovery (Liu et al., 2017; Li et al., 
2017). Therefore, to investigate the individual effect of anti-inflammation on synaptic 
recovery from cortical injury, we applied dietary curcumin as another treatment in the 
present study.  
We found in the present study that microglia had smaller particle size in the 
curcumin treated group, which implied that there was a potential morphology change in 
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microglia (Figure 15b). However, no significant differences were found for synaptic 
markers and synapse-microglia overlap, which might be due to the small sample size. 
These results demonstrated that the curcumin treatment did modulated neuroinflammatory 
responses and therefore warrant further study. A larger sample and and an analysis of the 
morphology analysis on microglia and the reconstruction of dendritic spines is necessary 
to confirm the effect of curcumin on microglia status and synapse-microglia interaction.   
Although curcumin was found to mediate inflammation and microglia activity, no 
significant change was found in the VGLUTs expression. This result indicated that the 
curcumin treatment was able to modulate neuroinflammation and reduce the microglial 
activity on synapses, but no evidence supported that this modulatory effect could increase 
the density of excitatory synapses. These data showed that even though both exosomes and 
curcumin showed anti-inflammatory properties, the underlying molecular mechanisms 
may still be different from each other by having different targets. Therefore, the similar 
anti-inflammatory effect resulted in different consequences. 
 
4.4 Limitations and future direction 
As discussed above, exosome treatment was found to improve the synaptic 
reconnection by reducing inflammatory responses, while curcumin modulated 
neuroinflammation but no synaptic changes were found. However, due to the limitations 
in the present study, it might be too early to conclude that curcumin has no effect on the 
recovery of synaptic connection. Compared to the exosomes part, the story of the curcumin 
 
49 
treatment is less comprehensive and was conducted in a limited sample size. First, no data 
for postsynaptic GluRs was reported for the curcumin treated animals. It made the effect 
of curcumin on postsynaptic components unclear due to this deficiency. The apposition of 
microglia on reconstructed dendrites was not reported for curcumin treated animals as well. 
Therefore, we are missing another side of microglia-synaptic interaction in the curcumin 
treatment. Second, the modulating effect on neuroinflammatory responses is not fully 
completed yet for either exosome or curcumin treatment. To understand the mechanism of 
both treatments better, it is necessary to know the morphology change of microglia as well 
as the level of proinflammatory cytokines under different treatments. Third, the study 
design had a limitation on sex of both exosomes treated and curcumin treated group. It was 
purely female animals in the exosome treated group and purely male in the curcumin 
treated group. The vehicle treated group that was sex-matched with the curcumin group 
only included one animal. This limitation on both sex and sample size may distort the 
results, and also makes it harder to interpret the effects.  
 
4.5 Other factors can contribute to the difference in recovery from cortical injury 
Biological sex has been suggested as an important factor that influence the outcome 
of cortical injury and following recovery. It was reported in a previous study that female 
rats have smaller lesions and less motor deficits than male rats with the same traumatic 
brain injury (TBI) (Free et al., 2017). Sex related difference has been found in the post-
injury recovery but not in neurodegeneration or cell death (Hall et al., 2005). In a study 
using the mouse model of TBI, female mice show greater cell proliferation in injured cortex 
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as compared with males (Xiong et al., 2007). Multiple studies have demonstrated that one 
major mechanism that lead to the sex difference in cortical injury is the inhibition of 
apoptotic to reduce cell death. Female rats were found to have upregulated X-linked 
inhibitor of apoptosis following injury, and the treatment of progesterone was found to 
reduce cell death by attenuating the apoptotic pathway (Bramlett et al., 2009; O’Connor et 
al., 2007). In addition, the sex difference may also impact the effectiveness of treatments. 
Norepinephrine was found to improve the post-injury recovery of cerebral blood flow in 
only female pigs but not in males (Armstead et al., 2016).  
The primary hormones including progesterone and estrogen have been suggested 
as neuroprotective and neuroregenerative especially in post-injury recovery (Stein, 2001). 
For example, exogenous estrogen was found to reduce proinflammatory cytokines and 
elevate anti-inflammatory IL-4 in ovariectomized female mice (Bruce-Keller et al., 2007). 
Estrogen was also reported to enhance the regeneration of dendritic spines and synapses, 
which might be attributed to the increased glial activity and the upregulation of insulin-like 
growth factor (IGF-1) and neutrophins (Toran-Allerand et al., 1992; Toran-Allerand, 2000). 
Estrogen can also reduce excitotoxicity by modulating the activity of glutamate receptors 
and attenuating the increase of intracellular Ca2+ (Stein, 2001; Goodman et al., 1996). 
In addition to the sex factor, therapeutic consequences may also vary with technical 
differences such as the dosage and the method of curcumin application. For example, 
previous studies showed that daily intraperitoneally administered curcumin for 4 weeks 
promoted motor recovery after nerve injuries in rats (Ma et al., 2013). The researchers also 
51 
found higher doses of curcumin (100 mg/kg and 300 mg/kg) exhibit better promotive effect 
as compared with low dose (50 mg/kg) (Ma et al., 2013).  
CONCLUSION 
In the present study, we investigated the cortical injury induced synaptic loss along 
with microglia activity, and demonstrated partial mechanism of mesenchymal-derived 
exosomes and dietary curcumin as two effective treatments. Our results suggest that 
cortical injury induces excitatory synaptic loss as well as increased synapse-microglia 
interaction. Both exosomes and curcumin treatment reduce the microglia activity on 
synapses, but only exosomes improve synaptic density. However, the mechanisms for both 
treatments are not fully uncovered yet. Even though both treatments exhibit anti-
inflammatory properties, they do not lead to the same therapeutic consequence. This result 
implies that, first, other potential mechanisms are involved in the exosomes treatment; 
second, similar anti-inflammatory strategies may have different targets and cellular 
mechanisms. Future study on these two treatments to examine the effect on 
proinflammatory cytokines to confirm the neuroinflammatory changes made by the 
treatment. In addition, other mechanisms can be investigated to illustrate the effect of the 
treatments. For example, curcumin was found to reduce the demyelination and apoptosis 
of oligodendrocytes (Yu et al., 2016). In the future projects, sex difference should also be 
considered as an important factor that may impact the effectiveness and therapeutic 
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